News

CT-011, an experimental anti-PD-1 monoclonal antibody, has also achieved secondary endpoint of overall survival (OS) in the Phase II trial. Initial analysis demonstrated that 70% of the patients

Originally developed by Roxro Pharma, Sprix is a prescription intranasal formulation of the analgesic ketorolac, a non-steroidal anti-inflammatory drug (NSAID). The spray is packaged in boxes that comprises

GBI is a cGMP contract manufacturer of monoclonal antibodies, recombinant proteins and vaccines. GBI also offers process development services from proof of concept and preclinical through phase II

Risperidone is an atypical antipsychotic that works by affecting certain substances in the brain. Risperidone tablets and Oral Solution are indicated for the treatment of schizophrenia. Alendronate tablets

Among the three products, two products have been transferred for pilot manufacturing and the remaining one product for full scale commercial manufacturing. Under the agreement, Teva will use

Crizotinib (also known as PF-02341066 or 1066) is an ALK (anaplastic lymphoma kinase) inhibitor of the aminopyridine chemical series. The FDA has granted priority review status for Pfizer‘s

The collaboration will work for the improvement, diagnosis and awareness of HCV infection in developed and emerging markets. The researchers of Merck and Roche are expected to investigate

In 2010, both the companies have signed a multi-year target validation agreement under which Tekmira offers Bristol-Myers Squibb with LNP formulations designed to validate the function of certain

Millennium Healthcare Solutions subsidiaries include Millennium Coding & Billing Specialists, Millennium ProComm and Millennium Medical Devices. Millennium Coding & Billing Specialists has aligned itself with its strategic partners